Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Windtree Therapeutics, Inc. (WINT) had Free Cash Flow per Share of $-1.04 for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-14.92M |
|
-- |
|
-- |
|
$3.98M |
|
$-3.98M |
|
$-6.65M |
|
$-10.63M |
|
$-10.63M |
|
$-10.63M |
|
$-10.63M |
|
$-10.63M |
|
$-10.63M |
|
$-3.98M |
|
$-3.97M |
|
4.88M |
|
4.88M |
|
$-3.06 |
|
$-3.06 |
|
| Balance Sheet Financials | |
$6.79M |
|
$0.08M |
|
$25.04M |
|
$31.83M |
|
$15.72M |
|
-- |
|
$12.50M |
|
$28.22M |
|
$3.61M |
|
$-20.52M |
|
$3.61M |
|
9.25M |
|
| Cash Flow Statement Financials | |
$-5.06M |
|
$-5.18M |
|
$8.77M |
|
$1.79M |
|
$0.31M |
|
$-1.48M |
|
$0.10M |
|
-- |
|
$-0.09M |
|
| Fundamental Metrics & Ratios | |
0.43 |
|
-- |
|
-- |
|
-- |
|
2.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-294.82% |
|
51.80% |
|
-33.40% |
|
-294.81% |
|
$0.39 |
|
|
Free Cash Flow per Share |
$-1.04 |
$-1.04 |
|